Amrize Ltd
AMRZ· NYSE
AMRZAmrize Ltd
Filed Oct 29, 2025 · 10-Q · 29 days after period end · 0002035989-25-000037
| Metric | Q3 2025 | Q3 2024 |
|---|---|---|
| Revenue | $3.68B | $3.45B |
| Net Income | $545.00M | $553.00M |
| EPS Diluted | $0.98 | $1.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amrize Ltd · CIK 2035989 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Oct 29, 2025 · 29 d after period end
